BioLife Solutions, Inc.
BLFS
$23.95
-$0.79-3.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.50M | 24.76M | 28.07M | 25.42M | 22.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.50M | 24.76M | 28.07M | 25.42M | 22.05M |
| Cost of Revenue | 10.00M | 9.25M | 10.15M | 8.99M | 7.25M |
| Gross Profit | 17.50M | 15.52M | 17.92M | 16.43M | 14.80M |
| SG&A Expenses | 14.73M | 13.46M | 14.60M | 14.13M | 13.79M |
| Depreciation & Amortization | 85.00K | 66.00K | 699.00K | 708.00K | 66.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.47M | 24.84M | 28.16M | 26.54M | 22.55M |
| Operating Income | 27.00K | -80.00K | -89.00K | -1.12M | -499.00K |
| Income Before Tax | 1.25M | 1.94M | 703.00K | -15.71M | 285.00K |
| Income Tax Expenses | 62.00K | -173.00K | 82.00K | 126.00K | 14.00K |
| Earnings from Continuing Operations | 1.19M | 2.11M | 621.00K | -15.84M | 271.00K |
| Earnings from Discontinued Operations | -- | 8.96M | -- | -- | -719.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.19M | 11.07M | 621.00K | -15.84M | -448.00K |
| EBIT | 27.00K | -80.00K | -89.00K | -1.12M | -499.00K |
| EBITDA | 726.00K | 506.00K | 1.25M | 260.00K | 11.00K |
| EPS Basic | 0.02 | 0.23 | 0.01 | -0.33 | -0.01 |
| Normalized Basic EPS | 0.01 | 0.03 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.02 | 0.22 | 0.01 | -0.33 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 48.46M | 48.14M | 47.93M | 47.80M | 47.13M |
| Average Diluted Shares Outstanding | 49.25M | 49.01M | 48.72M | 47.80M | 48.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |